Federal Judge Allows Kirkland & Ellis to Exit Novartis Case Amid Conflict of Interest Concerns
In a notable development in the pharmaceutical legal landscape, a New York federal judge has accepted the withdrawal of the entire Kirkland & Ellis LLP team from representing Novartis Pharma. This move comes in the wake of a challenge from Regeneron Pharmaceuticals, which sought disqualification of the legal team due to an “unthinkable” conflict of…